About Transcatheter Technology
Transcatheter Technology is a Healthcare company based in Regensburg (Germany) founded in 2009, and was acquired by Venus MedTech in April 2016. Catheter-based heart valve implantation and aortic therapy systems are developed. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Transcatheter Technologies GmbH. Its competitors include TRiCares and Transcatheter Technologies; 2 of its 2 listed competitors have raised funding.
Company details
Transcatheter Technologies develops catheter-based heart valve implantation and aortic therapy systems. The company has developed transcatheter mitral valve system, transapical aortic valve system, and endovascular aortic repair and sealing system. The company also develops a platform technology for folding its self-expanding valve prostheses and endovascular stents via an inner catheter without the need for an outer sheath.
- Headquarters Regensburg, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website transcatheter-technology.com
- Acquired by Venus MedTech (Apr 2016)
- Legal Name Transcatheter Technologies Gmbh
- Investors
- Acquired byVenus MedTech
(Apr 2016)
Investors in Transcatheter Technology
Transcatheter Technology has secured backing from 1 investor. Prominent investors backing the company include Venus MedTech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures. | 2009 | venusmedtech.com | Hangzhou, China |
Investor details for Transcatheter Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Transcatheter Technology
2 dated milestones of Transcatheter Technology across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Transcatheter Technology is founded.
- Exit Acquired by Venus MedTech.
Competitors of Transcatheter Technology
Transcatheter Technology has 2 listed competitors in our database, 2 of them funded. They include TRiCares and Transcatheter Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tricares.com | 2013 | Aschheim, Germany | $102.84M | Minimally invasive tricuspid valve replacement system is developed. | ||
| transcatheter-technologies.com | 2009 | Regensburg, Germany | $6.7M | Implantable devices for heart valve repair and replacement |
Detailed competitors of Transcatheter Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Transcatheter Technology
Transcatheter Technology was founded in 2009.
Transcatheter Technology is headquartered in Regensburg, Germany. It is registered at Regensburg, Bavaria, Germany.
Transcatheter Technologies develops catheter-based heart valve implantation and aortic therapy systems. The company has developed transcatheter mitral valve system, transapical aortic valve system, and endovascular aortic repair and sealing system. The company also develops a platform technology for folding its self-expanding valve prostheses and endovascular stents via an inner catheter without the need for an outer sheath.
Transcatheter Technology's top competitors include TRiCares and Transcatheter Technologies.
Transcatheter Technology has 1 investor. Key investors include Venus MedTech.
Transcatheter Technology operates through Transcatheter Technologies Gmbh.
Yes. Transcatheter Technology was acquired by Venus MedTech in April 2016.